Baluarte, Antonio .
HRN: 00-65-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2022
LEVOFLOXACIN 500MG (TAB)
12/15/2022
12/21/2022
PO
750mg
OD
CAP MR COPD In AE
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes